InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by DIAMOND STUART. Officer active across 1 company, notably bioAffinity Technologies, Inc.. Aggregated, 5 reports have been published. Split: 1 buy · 0 sell. Activity tracked since 1 January 2023. The latest transaction was filed on 1 July 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations